• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血根碱在光生物测定中的应用:概述。

Hypericin in photobiological assays: An overview.

机构信息

Centro de Ciências Naturais e Humanas (CCNH), Universidade Federal do ABC, Av. dos Estados, 5001, Bairro Bangú, Santo André, SP, Brasil.

Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), Rua Três de Maio, 100, Vila Clementino, São Paulo, SP, Brasil.

出版信息

Photodiagnosis Photodyn Ther. 2021 Sep;35:102343. doi: 10.1016/j.pdpdt.2021.102343. Epub 2021 May 24.

DOI:10.1016/j.pdpdt.2021.102343
PMID:34038765
Abstract

Hypericin is considered a potent photosensitizer for use in antitumor and antimicrobial photodynamic therapy (PDT). This review presents the primary biological results obtained with hypericin in photodynamic therapy applications, such as photodynamic cancer treatment, photoinactivation of microorganisms (PDI), tissue scarring, and photo diagnosis. We present a compilation of in vitro results that have been published thus far; for these studies, we highlight the hypericin concentration, light dose, and other experimental conditions to evaluate the efficiency of photodynamic treatment like cell death, cell viability, or cell proliferation. The results indicate that different hypericin phototoxicity levels can be observed according to the specific light dose and concentration. Furthermore, it was shown that cellular localization and cell death mechanisms (apoptosis and necrosis) are dependent on the cell type.

摘要

金丝桃素被认为是一种有效的光敏剂,可用于抗肿瘤和抗菌光动力疗法(PDT)。本文综述了金丝桃素在光动力治疗应用中的主要生物学研究结果,如光动力癌症治疗、微生物光灭活(PDI)、组织瘢痕形成和光诊断。我们汇集了迄今为止已发表的体外研究结果;对于这些研究,我们强调了金丝桃素浓度、光剂量和其他实验条件,以评估光动力治疗的效率,如细胞死亡、细胞活力或细胞增殖。结果表明,根据特定的光剂量和浓度,可以观察到不同的金丝桃素光毒性水平。此外,还表明细胞定位和细胞死亡机制(凋亡和坏死)取决于细胞类型。

相似文献

1
Hypericin in photobiological assays: An overview.血根碱在光生物测定中的应用:概述。
Photodiagnosis Photodyn Ther. 2021 Sep;35:102343. doi: 10.1016/j.pdpdt.2021.102343. Epub 2021 May 24.
2
Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.金丝桃素光动力疗法通过诱导细胞凋亡和抑制病毒转录来抑制成人 T 细胞白血病细胞的生长。
Retrovirology. 2019 Feb 19;16(1):5. doi: 10.1186/s12977-019-0467-0.
3
The multifaceted photocytotoxic profile of hypericin.金丝桃素多效光细胞毒性特征。
Mol Pharm. 2009 Nov-Dec;6(6):1775-89. doi: 10.1021/mp900166q.
4
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.由非相干光源激活的金丝桃素对食管癌细胞具有光动力效应。
Int J Colorectal Dis. 2003 May;18(3):239-47. doi: 10.1007/s00384-002-0440-5. Epub 2002 Nov 14.
5
Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model.金丝桃素光动力疗法在RIF-1小鼠肿瘤模型中诱导血管损伤和细胞凋亡。
Int J Cancer. 2002 Mar 10;98(2):284-90. doi: 10.1002/ijc.10175.
6
St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.圣约翰草(贯叶连翘)光医学:金丝桃素光动力疗法诱导转移性黑色素瘤细胞死亡。
PLoS One. 2014 Jul 30;9(7):e103762. doi: 10.1371/journal.pone.0103762. eCollection 2014.
7
Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.抑制 ABCG2 可能会增强血啉介导的光动力疗法在结直肠癌细胞球体模型中的疗效。
Photodiagnosis Photodyn Ther. 2018 Sep;23:221-229. doi: 10.1016/j.pdpdt.2018.06.027. Epub 2018 Jun 30.
8
Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.金丝桃素及其放射性碘标记衍生物——一种治疗儿童肺泡横纹肌肉瘤细胞的新联合方法。
Photodiagnosis Photodyn Ther. 2020 Mar;29:101588. doi: 10.1016/j.pdpdt.2019.101588. Epub 2019 Nov 6.
9
In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.金丝桃素促进的小儿上皮性肝肿瘤的体外光动力治疗
Oncol Rep. 2008 Nov;20(5):1277-82.
10
Modifying excitation light dose of novel photosensitizer PVP-Hypericin for photodynamic diagnosis and therapy.改变新型光敏剂 PVP-Hypericin 的激发光剂量用于光动力诊断和治疗。
J Photochem Photobiol B. 2013 Mar 5;120:120-9. doi: 10.1016/j.jphotobiol.2012.12.013. Epub 2013 Jan 10.

引用本文的文献

1
Advancements in Nanocarrier Delivery Systems for Photodynamic Therapy in Lung Cancer.用于肺癌光动力治疗的纳米载体递送系统的进展
Int J Nanomedicine. 2025 May 29;20:6853-6874. doi: 10.2147/IJN.S521444. eCollection 2025.
2
The Search for Drugs Derived from Natural Products for Infection Treatment in the Last 20 Years - A Systematic Review.过去 20 年中从天然产物寻找抗感染治疗药物的研究进展——系统性综述。
Curr Top Med Chem. 2024;24(22):1960-1999. doi: 10.2174/0115680266299409240606062235.
3
PA12 Surface Treatment and Its Effect on Compatibility with Nutritional Culture Medium to Maintain Cell Vitality and Proliferation.
PA12表面处理及其对与营养培养基相容性的影响,以维持细胞活力和增殖。
Bioengineering (Basel). 2024 Apr 30;11(5):442. doi: 10.3390/bioengineering11050442.
4
Hypericin-Based Photodynamic Therapy Displays Higher Selectivity and Phototoxicity towards Melanoma and Squamous Cell Cancer Compared to Normal Keratinocytes In Vitro.基于金丝桃素的光动力疗法在体外对黑色素瘤和鳞状细胞癌显示出比正常角质形成细胞更高的选择性和光毒性。
Int J Mol Sci. 2023 Nov 29;24(23):16897. doi: 10.3390/ijms242316897.
5
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.纳米技术在中药有效成分中的高级应用。
J Nanobiotechnology. 2023 Nov 29;21(1):456. doi: 10.1186/s12951-023-02165-x.
6
Photosensitizers-Loaded Nanocarriers for Enhancement of Photodynamic Therapy in Melanoma Treatment.用于增强黑色素瘤治疗中光动力疗法的载光敏剂纳米载体
Pharmaceutics. 2023 Aug 11;15(8):2124. doi: 10.3390/pharmaceutics15082124.
7
Potent Virucidal Activity In Vitro of Photodynamic Therapy with Extract as Photosensitizer and White Light against Human Coronavirus HCoV-229E.以提取物为光敏剂并用白光进行光动力疗法对人冠状病毒HCoV-229E的体外强效杀病毒活性。
Pharmaceutics. 2022 Nov 2;14(11):2364. doi: 10.3390/pharmaceutics14112364.
8
Hypericin, a potential new BH3 mimetic.金丝桃素,一种潜在的新型BH3模拟物。
Front Pharmacol. 2022 Oct 4;13:991554. doi: 10.3389/fphar.2022.991554. eCollection 2022.